Bausch Health Cos ROE 2010-2024 | BHC
Current and historical return on equity (ROE) values for Bausch Health Cos (BHC) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Bausch Health Cos ROE - Return on Equity Historical Data |
| Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
| 2024-09-30 |
$-0.18B |
$-0.24B |
98.21% |
| 2024-06-30 |
$-0.47B |
$-0.23B |
262.40% |
| 2024-03-31 |
$-0.46B |
$-0.17B |
827.27% |
| 2023-12-31 |
$-0.59B |
$-0.08B |
-2391.92% |
| 2023-09-30 |
$-0.96B |
$-0.24B |
-873.47% |
| 2023-06-30 |
$-0.19B |
$0.27B |
-67.09% |
| 2023-03-31 |
$-0.36B |
$0.15B |
-130.89% |
| 2022-12-31 |
$-0.23B |
$0.26B |
-111.80% |
| 2022-09-30 |
$0.25B |
$0.43B |
198.83% |
| 2022-06-30 |
$0.04B |
$0.25B |
-301.75% |
| 2022-03-31 |
$-0.41B |
$-0.14B |
176.76% |
| 2021-12-31 |
$-0.95B |
$-0.03B |
419.47% |
| 2021-09-30 |
$-1.17B |
$-0.14B |
1766.04% |
| 2021-06-30 |
$-1.29B |
$-0.61B |
-980.57% |
| 2021-03-31 |
$-1.02B |
$-0.12B |
-242.09% |
| 2020-12-31 |
$-0.56B |
$0.61B |
-86.29% |
| 2020-09-30 |
$-1.92B |
$0.66B |
-245.99% |
| 2020-06-30 |
$-2.04B |
$0.55B |
-162.40% |
| 2020-03-31 |
$-1.89B |
$0.79B |
-105.27% |
| 2019-12-31 |
$-1.79B |
$1.14B |
-78.05% |
| 2019-09-30 |
$-0.62B |
$2.56B |
-22.73% |
| 2019-06-30 |
$-0.92B |
$2.69B |
-31.84% |
| 2019-03-31 |
$-1.62B |
$2.78B |
-52.27% |
| 2018-12-31 |
$-4.15B |
$2.82B |
-117.40% |
| 2018-09-30 |
$-3.29B |
$3.24B |
-76.26% |
| 2018-06-30 |
$-1.64B |
$3.56B |
-33.73% |
| 2018-03-31 |
$-0.81B |
$4.52B |
-16.17% |
| 2017-12-31 |
$2.40B |
$5.94B |
49.60% |
| 2017-09-30 |
$1.38B |
$5.42B |
32.95% |
| 2017-06-30 |
$-1.14B |
$4.03B |
-29.39% |
| 2017-03-31 |
$-1.41B |
$3.99B |
-33.24% |
| 2016-12-31 |
$-2.41B |
$3.26B |
-51.50% |
| 2016-09-30 |
$-2.28B |
$4.27B |
-42.45% |
| 2016-06-30 |
$-1.01B |
$5.40B |
-17.10% |
| 2016-03-31 |
$-0.76B |
$5.78B |
-12.29% |
| 2015-12-31 |
$-0.29B |
$6.03B |
-4.54% |
| 2015-09-30 |
$0.60B |
$6.47B |
9.55% |
| 2015-06-30 |
$0.82B |
$6.56B |
13.83% |
| 2015-03-31 |
$1.00B |
$6.58B |
17.73% |
| 2014-12-31 |
$0.88B |
$5.40B |
16.60% |
| 2014-09-30 |
$0.50B |
$5.23B |
9.54% |
| 2014-06-30 |
$-0.75B |
$5.37B |
-14.30% |
| 2014-03-31 |
$-0.86B |
$5.20B |
-16.24% |
| 2013-12-31 |
$-0.87B |
$5.23B |
-17.69% |
| 2013-09-30 |
$-1.08B |
$5.06B |
-23.89% |
| 2013-06-30 |
$-0.10B |
$5.70B |
-2.33% |
| 2013-03-31 |
$-0.13B |
$3.59B |
-3.54% |
| 2012-12-31 |
$-0.12B |
$3.72B |
-3.04% |
| 2012-09-30 |
$0.03B |
$3.79B |
0.75% |
| 2012-06-30 |
$0.06B |
$3.70B |
1.58% |
| 2012-03-31 |
$0.14B |
$4.08B |
3.36% |
| 2011-12-31 |
$0.16B |
$3.93B |
3.67% |
| 2011-09-30 |
$0.07B |
$4.01B |
1.57% |
| 2011-06-30 |
$-0.18B |
$4.67B |
-3.61% |
| 2011-03-31 |
$-0.20B |
$4.71B |
-4.87% |
| 2010-12-31 |
$-0.21B |
$4.91B |
-6.42% |
| 2010-09-30 |
$-0.10B |
$5.35B |
-4.42% |
| 2010-06-30 |
$0.14B |
$1.36B |
10.77% |
| 2010-03-31 |
$0.13B |
$1.34B |
10.22% |
| 2009-12-31 |
$0.18B |
$1.35B |
13.87% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$3.597B |
$8.757B |
|
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|
